vidarabine phosphate has been researched along with Acute Lymphoid Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albo, C; Benítez, E; Constenla, MI; Plaza, J; Poderós, C | 1 |
| Avramis, VI; Champagne, J; Ettinger, LJ; Finkelstein, J; Hammond, GD; Holcenberg, JS; Krailo, M; Poplack, DG; Reaman, G; Sato, J | 1 |
1 trial(s) available for vidarabine phosphate and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Pharmacology of fludarabine phosphate after a phase I/II trial by a loading bolus and continuous infusion in pediatric patients.
Topics: Antimetabolites, Antineoplastic; Arabinofuranosylcytosine Triphosphate; Child, Preschool; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Vidarabine Phosphate | 1990 |
1 other study(ies) available for vidarabine phosphate and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
[Peritoneal tuberculosis in a patient with chronic lymphatic leukemia in treatment with fludarabine].
Topics: Adenosine Deaminase; Aged; Biomarkers; False Negative Reactions; Fatal Outcome; Female; Humans; Immunity, Cellular; Immunocompromised Host; Opportunistic Infections; Peritonitis, Tuberculous; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tuberculin Test; Vidarabine Phosphate | 1996 |